Related Experiment Video
Updated: Aug 31, 2025

Isolation and Identification of Extravascular Immune Cells of the Heart
Published on: August 23, 2018
Cardiac sarcoidosis and giant cell myocarditis after COVID-19 infection
Entela Bollano1,2, Christian Lars Polte2,3, Mikko I Mäyränpää4
1Department of Cardiology, Sahlgrenska University Hospital, 413 45, Gothenburg, Sweden.
Abstract:
Patients infected with SARS-CoV-2 have varying manifestations of cardiac involvement. We report four patients presenting with symptomatic cardiac sarcoidosis (CS) or giant cell myocarditis (GCM) 1-8 months after mild COVID-19. All patients received immunosuppressive therapy and improved gradually within the following months. The possible temporal association between the CS/GCM and COVID-19 infection might suggest that COVID-19 could be a trigger for granulomatous myocarditis.
More Related Videos
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Myocarditis III: Medical Management
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification

